Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome
I. Menoux (Strasbourg, France), D. Antoni (Strasbourg, France), P. Truntzer (Strasbourg, France), A. Keller (Strasbourg, France), G. Massard (Strasbourg, France), G. NoëL (Strasbourg, France)
Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2212
Disease area: Thoracic oncology
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Menoux (Strasbourg, France), D. Antoni (Strasbourg, France), P. Truntzer (Strasbourg, France), A. Keller (Strasbourg, France), G. Massard (Strasbourg, France), G. NoëL (Strasbourg, France). Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome. 2212
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: